XBB.1.5-containing messenger RNA-1273 vaccines administered as fifth doses to adults elicited potent and diverse neutralizing responses against Omicron XBB and other recent severe acute respiratory syndrome coronavirus 2 variants, supporting authorization and approval of monovalent XBB.1.5-containing vaccines for 2023-2024 immunizations.
All Keywords
【저자키워드】 COVID-19, mRNA vaccine, SARS-CoV-2 variants, JN.1, Omicron XBB.1.5,
【저자키워드】 COVID-19, mRNA vaccine, SARS-CoV-2 variants, JN.1, Omicron XBB.1.5,